Overview


Pharmaceuticals, commonly referred to as drugs or medications, are fascinating compounds that play a crucial role in our health and well-being. Whether sourced from the earth, like plants and minerals, or created in state-of-the-art laboratories, these substances are designed to help diagnose, prevent, treat, or manage a wide array of diseases, disorders, and medical conditions in both humans and animals.

These medications come in various forms—think tablets, capsules, injections, creams, and liquids—making them easy to administer and effectively absorbed by the body. Each formulation is carefully crafted to ensure that patients receive the right dose at the right time.

Before any pharmaceutical can be prescribed, it undergoes stringent testing and evaluation, ensuring it meets rigorous standards set by health authorities. This thorough process guarantees that any medication available in the market is safe, effective, and of the highest quality.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Pharmaceutical Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Pharmaceutical Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • AbbVie Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Sanofi
  • GSK plc
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Eli Lilly and Company
  • Bayer AG
  • Amgen
  • Vertex Pharmaceuticals Incorporated

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Molecule Type

  • Biologics & Biosimilars (Large Molecules)
    • Monoclonal Antibodies
    • Vaccines
    • Cell & Gene Therapy
    • Others
  • Conventional Drugs (Small Molecules)

By Product

  • Branded
  • Generics

By Type 

  • Prescription
  • OTC

By Disease 

  • Cardiovascular diseases
  • Cancer
  • Diabetes
  • Infectious diseases
  • Neurological disorders
  • Respiratory diseases
  • Autoimmune diseases
  • Mental health disorders
  • Gastrointestinal disorders
  • Women’s Health Diseases
  • Genetic and rare genetic diseases
  • Dermatological conditions
  • Obesity
  • Renal diseases
  • Liver conditions
  • Hematological disorders
  • Eye conditions
  • Infertility conditions
  • Endocrine disorders
  • Allergies
  • Others

By Route of Administration 

  • Oral
  • Topical
  • Parenteral
    • Intravenous
    • Intramuscular
  • Inhalations
  • Other

By Formulation

  • Tablets
  • Capsules
  • Injectable
  • Sprays
  • Suspensions
  • Powders
  • Other Formulations

By Age Group 

  • Children & Adolescents
  • Adults
  • Geriatric

By End User

  • Hospitals
  • Clinics
  • Others

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis of the Pharmaceutical Market By Molecule Type, By Product, By Type, By Disease, By Formulation, By Age Group, By Route Of Administration, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Pharmaceutical Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Pharmaceutical Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Pharmaceutical Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Pharmaceutical Market, By Molecule Type Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Biologics & Biosimilars (Large Molecules)
        1.1. Monoclonal Antibodies
        1.2. Vaccines
        1.3. Cell & Gene Therapy
        1.4. Others
      2. Conventional Drugs (Small Molecules)
  • 8.  Pharmaceutical Market, By Product Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Branded
      2. Generics
  • 9.  Pharmaceutical Market, By Type Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Prescription
      2. OTC
  • 10.  Pharmaceutical Market, By Disease Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Cardiovascular diseases
      2. Cancer
      3. Diabetes
      4. Infectious diseases
      5. Neurological disorders
      6. Respiratory diseases
      7. Autoimmune diseases
      8. Mental health disorders
      9. Gastrointestinal disorders
      10. Women’s Health Diseases
      11. Genetic and rare genetic diseases
      12. Dermatological conditions
      13. Obesity
      14. Renal diseases
      15. Liver conditions
      16. Hematological disorders
      17. Eye conditions
      18. Infertility conditions
      19. Endocrine disorders
      20. Allergies
      21. Others
  • 11.  Pharmaceutical Market, By Route of Administration Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Oral
      2. Topical
      3. Parenteral
        3.1. Intravenous
        3.2. Intramuscular
      4. Inhalations
      5. Other
  • 12.  Pharmaceutical Market, By Formulation Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Tablets
      2. Capsules
      3. Injectable
      4. Sprays
      5. Suspensions
      6. Powders
      7. Other Formulations
  • 13.  Pharmaceutical Market, By Age Group Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Children & Adolescents
      2. Adults
      3. Geriatric
  • 14.  Pharmaceutical Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Hospitals
      2. Clinics
      3. Others
  • 15.  North America Pharmaceutical Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 16.  Latin America Pharmaceutical Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 17.  Europe Pharmaceutical Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 18.  Asia Pacific Pharmaceutical Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 19.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 20.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 21.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Drug Types Offered and Financial Layouts)
    •    1. F. Hoffmann-La Roche Ltd.
        1.1. Company Overview
        1.2. Drug Type Portfolio
        1.3. SWOT Analysis
        1.4. Financial Overview
        1.5. Strategic Overview
         2. Novartis AG
        2.1. Company Overview
        2.2. Drug Type Portfolio
        2.3. SWOT Analysis
        2.4. Financial Overview
        2.5. Strategic Overview
         3. AbbVie Inc.
        3.1. Company Overview
        3.2. Drug Type Portfolio
        3.3. SWOT Analysis
        3.4. Financial Overview
        3.5. Strategic Overview
         4. Johnson & Johnson Services, Inc.
        4.1. Company Overview
        4.2. Drug Type Portfolio
        4.3. SWOT Analysis
        4.4. Financial Overview
        4.5. Strategic Overview
         5. Merck & Co., Inc.
        5.1. Company Overview
        5.2. Drug Type Portfolio
        5.3. SWOT Analysis
        5.4. Financial Overview
        5.5. Strategic Overview
         6. Pfizer Inc.
        6.1. Company Overview
        6.2. Drug Type Portfolio
        6.3. SWOT Analysis
        6.4. Financial Overview
        6.5. Strategic Overview
         7. Bristol-Myers Squibb Company
        7.1. Company Overview
        7.2. Drug Type Portfolio
        7.3. SWOT Analysis
        7.4. Financial Overview
        7.5. Strategic Overview
         8. Sanofi
        8.1. Company Overview
        8.2. Drug Type Portfolio
        8.3. SWOT Analysis
        8.4. Financial Overview
        8.5. Strategic Overview
         9. GSK plc
        9.1. Company Overview
        9.2. Drug Type Portfolio
        9.3. SWOT Analysis
        9.4. Financial Overview
        9.5. Strategic Overview
        10. Takeda Pharmaceutical Company Limited
        10.1. Company Overview
        10.2. Drug Type Portfolio
        10.3. SWOT Analysis
        10.4. Financial Overview
        10.5. Strategic Overview
        11. AstraZeneca (U.K.)
        11.1. Company Overview
        11.2. Drug Type Portfolio
        11.3. SWOT Analysis
        11.4. Financial Overview
        11.5. Strategic Overview
        12. Eli Lilly and Company
        12.1. Company Overview
        12.2. Drug Type Portfolio
        12.3. SWOT Analysis
        12.4. Financial Overview
        12.5. Strategic Overview
        13. Bayer AG
        13.1. Company Overview
        13.2. Drug Type Portfolio
        13.3. SWOT Analysis
        13.4. Financial Overview
        13.5. Strategic Overview
        14. Amgen
        14.1. Company Overview
        14.2. Drug Type Portfolio
        14.3. SWOT Analysis
        14.4. Financial Overview
        14.5. Strategic Overview
        15. Vertex Pharmaceuticals Incorporated
        15.1. Company Overview
        15.2. Drug Type Portfolio
        15.3. SWOT Analysis
        15.4. Financial Overview
        15.5. Strategic Overview

  • 22.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 23.  FutureWise SME Key Takeaway Points for Client
    •     

Partner

Our Clients